| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| May 1, 2026 | ±1.5% | +1.4% | over-priced |
| October 31, 2025 | ±1.6% | -2.7% | under-priced |
| August 1, 2025 | ±1.4% | -0.2% | over-priced |
| May 1, 2025 | ±1.7% | -1.1% | over-priced |
| October 31, 2024 | ±1.0% | -3.6% | under-priced |
| August 2, 2024 | ±1.7% | +0.1% | over-priced |
| May 2, 2024 | ±1.4% | -5.2% | under-priced |
| October 26, 2023 | ±1.6% | +1.6% | — |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $3.98 | $8.8B | $1.9B |
| Q4 FY2025 | $3.27 | $8.8B | $1.6B |
| Q3 FY2025 | $4.09 | $8.6B | $2.0B |
| Q2 FY2025 | $3.73 | $8.5B | $1.8B |
Linde plc Ordinary Share (LIN) reports in 93 days, with the next report estimated for September 14, 2026. Across the last 8 reports, options priced an average ±1.5% earnings move while the stock actually moved 2.0% on average — the market has been roughly fair on LIN's earnings risk. Fundamentals into the print: EPS up 13.4% year-over-year, revenue up 8.2%. QuantLogix's live 5-factor engine currently reads LIN as a buy at 69/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →